Astek Diagnostics, Inc. — Form D/A

Astek Diagnostics, Inc. of Halethorpe, MD, a company, filed a Form D amendment with the SEC on 2023-06-08. The offering totals $2.0M, of which $1.2M was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-06-08
Form: D/A
Accession: 0001972498-23-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $2.0M
Amount sold: $1.2M
Remaining: $845K
Minimum investment: $5K
Investors: 10
Date of first sale: 2023-03-22
Revenue range: Decline to Disclose
SEC file number: 021-477995

Issuer

Name: Astek Diagnostics, Inc.
CIK: 0001972498
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 1450 S. Rolling Road, Halethorpe, MD, 21227
Phone: 484-459-8258

Officers, directors & promoters (2)

Name	Role	Location
Mustafa Al-Adhami	Director	Halethorpe, MD
Mustafa Al-Adhami	Executive Officer	Halethorpe, MD

Other filings by this issuer (7)

Filed	Form	Offering	Sold
2025-04-28	D	$1.5M	$750K
2023-10-19	D	$2.5M	$1.1M
2023-08-28	D	$350K	$350K
2023-08-28	D	$150K	$150K
2023-08-28	D	$345K	$345K
2023-08-28	D/A	$2.0M	$1.4M
2023-04-05	D	$2.0M	$1.0M

More